The purpose of this project is to build malaria research capacity through a dual approach of research and hands-on mentorship activities. These approaches will catalyse advancement of science, strengthen research leadership, and on-site capacity building.
Realizing Effectiveness Across Continents with Hydroxyurea (REACH) is a prospective, phase I/II open-label dose escalation trial of hydroxyurea for children with confirmed Sudden Cardiac Arrest (SCA) between 12 months and 10 years.
The Transfusion and Treatment of severe Anaemia in African Children (TRACT) is a randomised controlled Trial. TRACT is evaluating three different ways to reduce short and longer-term mortality and morbidity following admission to hospital with severe anaemia in African children.
The clinical trial mainly involves assessing the tolerability and safety of SLDPQ – Single Low Dose Primaquine in African Children with acute uncomplicated falciparum malaria and glucose 6 phosphate dehydrogenase deficiency.
TABS PKPD is clinical trial involving the investigation of Pharmacokinetics and Pharmacodynamics of Azithromycin in severe malaria and baterial co-infection in African Children.